Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | SDHA | P31040 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CALML3 | P27482 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 8/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3519046 | 1.00 | MAOB (0.46) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3525477 | 0.92 | MAOB (0.47) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3526403 | 0.92 | MAOB (0.47) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3519815 | 0.90 | MAOB (0.48) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3519820 | 0.90 | MAOB (0.48) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3526326 | 0.88 | F10 (0.47) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3519964 | 0.88 | MAOB (0.48) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3519969 | 0.88 | MAOB (0.48) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3526323 | 0.88 | F10 (0.47) | MAOBPTGS1SDHAMAOALMNA | |
| SCHEMBL3519113 | 0.88 | MAOB (0.46) | MAOBPTGS1SDHAMAOALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7691889-B2 | Antimycobacterial compounds | LUPIN LIMITED (IN) | 2010-04-06 | — | — | US | disclosed |
| US-20050192275-A1 | Novel antimycobacterial compounds | LUPIN LIMITED (IN) | 2005-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192275-A1 | Novel antimycobacterial compounds | MDH1, IMMT, MLYCD | MAOB 2127/4885PTGS1 3926/4885SDHA 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.